HATTERAS BIOCAPITAL
Hatteras BioCapital, LLC is an investment advisory firm focused on clinical stage life science companies. Hatteras BioCapital is the General Partner of the Hatteras BioCapital Fund, LP. The Hatteras BioCapital Fund, LP is a single-purpose entity designed to invest in HBM BioCapital (USD), LP, a later stage, product focused life science fund.
HATTERAS BIOCAPITAL
Industry:
Financial Services
Address:
Durham, North Carolina, United States
Country:
United States
Website Url:
http://www.biovistacapital.com
Status:
Closed
Contact:
+1 919 484 0730
Email Addresses:
[email protected]
Official Site Inspections
http://www.biovistacapital.com
Unable to get host informations!!!
More informations about "Hatteras BioCapital"
Biovista Company Profile 2024: Valuation, Funding
Biovista General Information Description. Developer of an artificial intelligence-based biotechnology platform intended to deliver custom drug repositioning, drug de-risking, and clinical hold services for the biopharma industry.See details»
BioVista Capital (now Hatteras Venture Partners) - ContactOut
Hatteras Venture Partners is a venture capital firm that builds transformational companies in the areas of biopharmaceuticals, medical devices, diagnostics, healthcare IT, and related …See details»
Hatteras BioCapital - Crunchbase Company Profile & Funding
Hatteras BioCapital, LLC is an investment advisory firm focused on clinical stage life science companies. Hatteras BioCapital is the General Partner of the Hatteras BioCapital Fund, LP.See details»
Biovista - Wikipedia
Biovista Inc. is a private drug development services company based in Charlottesville, Virginia, US. Biovista's core business activities include drug repositioning and drug de-risking as well as disease cohort analysis, adverse event prediction and clinical hold analysis services. Biovista is also applying its technology platform to develop its own drug repositioning programs in the areas of central nervous system (CNS), diabetes/obesity, eye disorders, and oncology. See details»
Biovista Company Profile - Craft
Biovista is a company that provides drug repositioning and de-risking clinical solutions for the biopharma industry. It offers the Project Prodigy platform that enables augmented intelligence, …See details»
Drug Positioning and Prioritization - About us - Biovista
Sep 15, 2021 Biovista is a pioneer of AI and systematic drug repositioning We apply our systematic discovery Artificial Intelligence platform to develop our pipeline of repositioned drug candidates in disease areas such as …See details»
Biovista - Crunchbase Company Profile & Funding
Biovista is a pioneer of AI and systematic drug repositioning. They apply their systematic discovery Artificial Intelligence platform to develop their pipeline of repositioned drug candidates in disease areas such as neurodegenerative …See details»
Biovista’s Competitors, Revenue, Number of Employees, Funding
Biovista’s Profile, Revenue and Employees. Biovista is a drug development services company that focuses on neurodegenerative, epilepsy, oncology and orphan diseases. Biovista’s …See details»
Biovista Inc - Company Profile and News - Bloomberg Markets
Company profile page for Biovista Inc including stock price, company news, executives, board members, and contact informationSee details»
Pioneers in Systematic Drug Repositioning - Biovista
Recent Posts. Uberon OBO Contribution May 22, 2024; Navigating the biological unknown April 20, 2023; Quantum-Si and Biovista Partner to Provide AI-Driven Deep Proteomics Insights …See details»
Biovista | Drug Positioning and Prioritization - Home
Recent Posts. Uberon OBO Contribution May 22, 2024; Navigating the biological unknown April 20, 2023; Quantum-Si and Biovista Partner to Provide AI-Driven Deep Proteomics Insights from the Platinum™ Next-Generation Protein …See details»
Microbiome Insights Inc. Management Team | Org Chart
Microbiome Insights Inc. employs 13 employees. The Microbiome Insights Inc. management team includes Malcolm Kendall (Co-founder and CEO), Mike Fannon (Director), and Khoi Nguyen …See details»
Covista Capital - Investment Management
The fund has outperformed both US and Canadian indexes since its inception in 2015. As of Sep 30th 2024, an investment of $100,000 at inception would have more than tripled in value and …See details»
Drug Positioning and Prioritization - Contact Us - Biovista
Sep 15, 2021 Recent Posts. Uberon OBO Contribution May 22, 2024; Navigating the biological unknown April 20, 2023; Quantum-Si and Biovista Partner to Provide AI-Driven Deep …See details»
Vista Global Capital
Vista Global Capital is a capital advisory firm based in Toronto. We assist corporations and family offices raise debt and equity capital to fund their ventures.See details»
Accredited Investors & Limited Partners Welcome | Bellvista Capital
Bellvista Capital welcomes inquiries from accredited investors including potential Limited Partners, Professional Capital Allocators, and Funds of Funds.See details»
Bellavista Capital - Crunchbase Company Profile & Funding
Bellavista Capital, Inc. is located in Los Gatos, CA, United States and is part of the Heavy & Civil Engineering Construction IndustrySee details»
Current Investments - Nova Vida Capital
Oct 5, 2021 Orgzit (www.orgzit.com) is a leading SaaS company that provide an all-in-one Sales CRM solution for manufacturer sales reps and distributors.The software is used by more than …See details»
Drug Positioning and Prioritization - Solutions - Biovista
Sep 15, 2021 Biovista partners with biopharma companies, patient advocacy organizations, hospitals and other stakeholders in the healthcare space to create solutions that meet a range …See details»
Biovista | Drug Positioning and Prioritization - Our Vision
Sep 15, 2021 At Biovista we are working towards delivering innovative therapies more efficiently than has been practiced in the past. We believe that patients, healthcare providers and payors …See details»